Author(s): Ashok T. Jadhav, Kishorkumar B. Burade, Deepak A. Kulkarni, Sanjay S. Pekamwar, Shweta S. Kulkarni

Email(s): ashokambu@gmail.com

DOI: 10.52711/0974-360X.2022.00130   

Address: Ashok T. Jadhav1, Kishorkumar B. Burade1, Deepak A. Kulkarni2,3, Sanjay S. Pekamwar2, Shweta S. Kulkarni4
1Government College of Pharmacy, Karad, 415124, Maharashtra, India.
2School of Pharmacy, SRTM University, Nanded, 431606, Maharashtra, India.
3Srinath College of Pharmacy, Bajajnagar, Waluj, Aurangabad, 431136, Mahararashtra, India.
4Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune, 411018, Maharashtra, India.
*Corresponding Author

Published In:   Volume - 15,      Issue - 2,     Year - 2022


ABSTRACT:
Cefuroxime axetil (CA) is BCS class II drug and has 55% absolute oral bioavailability due to poor aqueous solubility hence the present work is an attempt to enhance the solubility and hence dissolution of CA by inclusion complexation with natural Cyclodextrins (CDs). The complexation efficiency of Cyclodextrin is low and hence large amount of CDs are required to solubilize small amount of poorly water-soluble drug. To overcome this limitation the hydrophilic polymers were used to improve the complexation efficiency of cyclodextrin through the formation of ternary complexes. In association with water soluble polymers like Polyvinyl Pyrrolidone (PVP) and Hydroxy Propyl Methyl Cellulose (HPMC) the complexation potential CDs (ß-CD and HP-ß-CD) was found to be improved which was analyzed by comparative evaluation of binary (drug: cyclodextrin) and ternary system (drug:cyclodextrin:polymer). Binary and ternary complexes were prepared by lyophilization method. On the basis of physicochemical characterization techniques like TLC, FTIR, DSC, and XRPD, the complex formation between CA, CD and water-soluble polymers was confirmed. The dissolution rate studies were also carried out in order to assess the in-vitro performance of complexes. Drug-HP-ß-CD-HPMC lyophilized system showed higher solubility and dissolution rate as compared to other systems.


Cite this article:
Ashok T. Jadhav, Kishorkumar B. Burade, Deepak A. Kulkarni, Sanjay S. Pekamwar, Shweta S. Kulkarni. Development and evaluation of drug-cyclodextrin-polymer ternary system of Cefuroxime axetil to enhance the solubility and dissolution efficiency. Research Journal of Pharmacy and Technology. 2022; 15(2):779-6. doi: 10.52711/0974-360X.2022.00130

Cite(Electronic):
Ashok T. Jadhav, Kishorkumar B. Burade, Deepak A. Kulkarni, Sanjay S. Pekamwar, Shweta S. Kulkarni. Development and evaluation of drug-cyclodextrin-polymer ternary system of Cefuroxime axetil to enhance the solubility and dissolution efficiency. Research Journal of Pharmacy and Technology. 2022; 15(2):779-6. doi: 10.52711/0974-360X.2022.00130   Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2022-15-2-50


REFERENCES:
1.    Kulkarni D, Pekamwar S. Crystal engineering an approach for solubility enhancement of poorly water soluble drugs. J Med Pharm Innov 2019;6:17-9.
2.    Loftsson T, Friðriksdóttir H. The effect of water-soluble polymers on the aqueous solubility and complexing abilities of β-cyclodextrin. International Journal of Pharmaceutics. 1998 Mar 18;163(1-2):115-21.
3.    Loftsson T, Másson M, Sigurjónsdóttir JF. Methods to enhance the complexation efficiency of cyclodextrins. STP Pharma Sciences. 1999 May 1;9(3):237-42.
4.    Danki L, Thube S. Studies on the Effect of Ternary Complex Formation of Simvastatin: β-Cyclodextrin with Polyvinyl Pyrrolidone and Hydroxypropyl Methylcellulose. Res J Pharm Technol. 2010;3(4):1148–51.
5.    Rao VM, Stella VJ. When can cyclodextrins be considered for solubilization purposes?. Journal of Pharmaceutical Sciences. 2003 May 1;92(5):927-32.
6.    Dhole SN, Kulkarni NS, Kuchekar BS. Preparation and characterization of ternary inclusion complex of aceclofenac-β-cyclodextrin Res J Pharm Technol. 2011; 4(5):750-755·
7.    Rajeswari C, Alka A, Javed A, Khar RK. Cyclodextrins in drug delivery. AAPS PharmSciTech. 2005;6(2):43.
8.    Balakrishna M, Rao GS, Ramanaiah M, Rao GN, Ramaraju B. Speciation studies of ternary complexes of Co(II), Ni(II), and Cu(II) with 5-Sulfosalicylic acid and 5-Hydroxysalicylic acid in Urea-water mixtures. Res J Pharm Technol. 2017;10(11):3681.
9.    Mathrusri A. Malineni K, Kunala A. New analytical technique for the determination of Epalrest in Pharmaceutical Dosage Forms by spectrophotometry. Res J Pharm Technol. 2017; 10(3): 739.
10.    Jagtap S, Magdum C. Influence of water-soluble polymers on epalrestat ternary complexation by kneading. Res J Pharm Technol. 2019;12(8):3602–8.
11.    Mapari AK. Stability Constants of Mixed Ligand Complexes of Transition Metal(II) ions with 1-[(1 E )- N -(2, 6-dichlorophenyl)ethanimidoyl]naphthalen-2-ol and 4-bromo-2-{( E )-[(2, 3-dimethylphenyl)imino]methyl}phenol. . Asian J Res Chem. 2017;10(2):131.
12.    Raju S, Kumar BA, Naik KBK, Rao GN. Chemical Speciation of Ternary Complexes of Co ( II ), Ni ( II ) and Cu ( II ) With L- Histidine and L-Glutamic Acid in Low Dielectric Media. Asian J Res Chem. 2011;4(12):1908–14.
13.    Pitha J, Hoshino T. Effects of ethanol on formation of inclusion complexes of hydroxypropyl cyclodextrins with testosterone or with methyl orange. International Journal of Pharmaceutics. 1992 Feb 25;80(1-3):243-51.
14.    Pekamwar S, Kulkarni D, Gadade D. Accidental Formation of Eutectics during Crystal Engineering of Lamotrigine. Asian Journal of Pharmaceutics. 2021;15(1):60–67.
15.    Gundu R, Pekamwar S, Shelke S, Kulkarni D. Sustained release formulation of Ondansetron HCl using osmotic drug delivery approach. Drug Dev Ind Pharm 2020;46:343-55.
16.    Veiga MD, Ahsan F. Study of surfactants/β-cyclodextrin interactions over mequitazine dissolution. Drug Development and Industrial Pharmacy. 1997 Jan 1;23(7):721-5.
17.    Szente L, Szejtli J. Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development. Advanced Drug Delivery Reviews. 1999 Mar 1;36(1):17-28.
18.    Gadade DD, Kulkarni DA, Rathi PB, Pekamwar SS, Joshi SS. Solubility enhancement of lornoxicam by crystal engineering. Indian Journal of Pharmaceutical Sciences. 2017 May 31;79(2):277-86.
19.    Mura P, Bettinetti GP, Cirri M, Maestrelli F, Sorrenti M, Catenacci L. Solid-state characterization and dissolution properties of naproxen–arginine–hydroxypropyl-β-cyclodextrin ternary system. European Journal of Pharmaceutics and Bio-Pharmaceutics. 2005 Jan 1;59(1):99-106.
20.    Bagade OM, Kad DR, Bhargude DN, BhosaleDR,Kahane SK. Consequences and Impose of Solubility Enhancement of Poorly Water Soluble Drugs. Research J. Pharm. and Tech. 2014; 7(5) 598-607.
21.    Ribeiro LS, Ferreira DC, Veiga FJ. Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with β-cyclodextrin and its sulfobutyl ether derivative in solution and solid state. European Journal of Pharmaceutical Sciences. 2003 Nov 1;20(3):253-66.
22.    Pose-Vilarnovo B, Rodrı́guez-Tenreiro C, dos Santos JF, Vázquez-Doval J, Concheiro A, Alvarez-Lorenzo C, Torres-Labandeira JJ. Modulating drug release with cyclodextrins in hydroxypropyl methylcellulose gels and tablets. Journal of Controlled Release. 2004 Feb 10;94(2-3):351-63.
23.    Kristinsson JK, Fridriksdóttir H, Thorisdottir S, Sigurdardottir AM, Stefansson E, Loftsson T. Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops. Aqueous humor pharmacokinetics in humans. Investigative Ophthalmology & Visual Science. 1996 May 1;37(6):1199-203.
24.    JagtapV A, TaleleAN, Bendale AR, NarkhedeS, JadhavA, VidyasagarG. Solubility Enhancement of Pioglitazone by Using Poloxamer (188 and 407) with the Help of Kneading Method. Research J. Pharm. and Tech. 2010; 3 (4): 1152-1157.
25.    Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. Journal of Pharmaceutical Sciences. 1996 Oct;85(10):1017-25.
26.    Ribeiro LS, Ferreira DC, Veiga FJ. Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with β-cyclodextrin and its sulfobutyl ether derivative In solution and solid state. European Journal of Pharmaceutical Sciences. 2003 Nov 1;20(3):253-66.
27.    Valero M, Pérez-Revuelta BI, Rodrı́guez LJ. Effect of PVP K-25 on the Formation of the naproxen: β-cyclodextrin complex. International Journal of Pharmaceutics. 2003 Mar 6;253(1-2):97-110.
28.    Ammar HO, Salama HA, Ghorab M, Mahmoud AA. Formulation and biological evaluation of glimepiride–cyclodextrin–polymer systems. International Journal of Pharmaceutics. 2006 Feb 17;309(1-2):129-38.
29.    Jelińska A, Dudzińska I, Zając M, Oszczpowicz I. The stability of the amorphous form of cefuroxime axetil in solid state. Journal of Pharmaceutical and Biomedical Analysis. 2006 Jun 7;41(3):1075-81.
30.    Zhang JY, Shen ZG, Zhong J, Hu TT, Chen JF, Ma ZQ, Yun J. Preparation of amorphous cefuroxime axetil nanoparticles by controlled nanoprecipitation method without surfactants. International Journal of Pharmaceutics. 2006 Oct 12;323(1-2):153-60.
31.    MS Gambhire, VM Gambhire, K Maske.Dissolution Enhancement of Clarithromycin by Formation of Surfactant Containing Microparticles. Research Journal of Pharmacy and Technology. 2010; 3(1):199-201.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available